​

Funding Round

Series B - Regenacy Pharmaceuticals

Series B - Regenacy Pharmaceuticals

Investment Firm

Overview

Regenacy Pharmaceuticals Provides Healthcare Services.

Announced Date

Aug 15, 2022

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Cobro Ventures

Cobro Ventures

Cobro Ventures is a early_stage_venture and seed firm.

Participant Investors

4

Investor Name
Participant InvestorCobro Ventures
Participant InvestorYonjin Venture
Participant Investor3E Bioventures
Participant InvestorTaiwania Capital Management Corporation

Round Details and Background

Regenacy Pharmaceuticals raised $9300000 on 2022-08-15 in Series B

Regenacy Pharmaceuticals Provides Healthcare Services.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 25, 2020
Series A - Regenacy Pharmaceuticals
7-undefined
Feb 09, 2022
Series B - Regenacy Pharmaceuticals
-7.8M
Aug 15, 2022
Series B - Regenacy Pharmaceuticals
4-9.3M

Recent Activity

There is no recent news or activity for this profile.